Frontiers in Immunology (Mar 2022)

Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm

  • Erica A. K. DePasquale,
  • Erica A. K. DePasquale,
  • Erica A. K. DePasquale,
  • Erica A. K. DePasquale,
  • Daniel Ssozi,
  • Daniel Ssozi,
  • Marina Ainciburu,
  • Jonathan Good,
  • Jonathan Good,
  • Jenny Noel,
  • Jenny Noel,
  • Martin A. Villanueva,
  • Martin A. Villanueva,
  • Martin A. Villanueva,
  • Martin A. Villanueva,
  • Martin A. Villanueva,
  • Martin A. Villanueva,
  • Charles P. Couturier,
  • Charles P. Couturier,
  • Charles P. Couturier,
  • Alex K. Shalek,
  • Alex K. Shalek,
  • Alex K. Shalek,
  • Alex K. Shalek,
  • Alex K. Shalek,
  • Alex K. Shalek,
  • Sary F. Aranki,
  • Hari R. Mallidi,
  • Gabriel K. Griffin,
  • Gabriel K. Griffin,
  • Gabriel K. Griffin,
  • Andrew A. Lane,
  • Andrew A. Lane,
  • Andrew A. Lane,
  • Andrew A. Lane,
  • Peter van Galen,
  • Peter van Galen,
  • Peter van Galen,
  • Peter van Galen

DOI
https://doi.org/10.3389/fimmu.2022.809414
Journal volume & issue
Vol. 13

Abstract

Read online

The immune system represents a major barrier to cancer progression, driving the evolution of immunoregulatory interactions between malignant cells and T-cells in the tumor environment. Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare acute leukemia with plasmacytoid dendritic cell (pDC) differentiation, provides a unique opportunity to study these interactions. pDCs are key producers of interferon alpha (IFNA) that play an important role in T-cell activation at the interface between the innate and adaptive immune system. To assess how uncontrolled proliferation of malignant BPDCN cells affects the tumor environment, we catalog immune cell heterogeneity in the bone marrow (BM) of five healthy controls and five BPDCN patients by analyzing 52,803 single-cell transcriptomes, including 18,779 T-cells. We test computational techniques for robust cell type classification and find that T-cells in BPDCN patients consistently upregulate interferon alpha (IFNA) response and downregulate tumor necrosis factor alpha (TNFA) pathways. Integrating transcriptional data with T-cell receptor sequencing via shared barcodes reveals significant T-cell exhaustion in BPDCN that is positively correlated with T-cell clonotype expansion. By highlighting new mechanisms of T-cell exhaustion and immune evasion in BPDCN, our results demonstrate the value of single-cell multiomics to understand immune cell interactions in the tumor environment.

Keywords